X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK vs CADILA HEALTHCARE - Comparison Results

MERCK    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK CADILA HEALTHCARE MERCK/
CADILA HEALTHCARE
 
P/E (TTM) x 57.0 17.6 324.3% View Chart
P/BV x 8.6 3.9 217.1% View Chart
Dividend Yield % 0.4 1.0 38.2%  

Financials

 MERCK   CADILA HEALTHCARE
EQUITY SHARE DATA
    MERCK
Dec-17
CADILA HEALTHCARE
Mar-18
MERCK/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,358558 243.3%   
Low Rs933362 258.1%   
Sales per share (Unadj.) Rs665.0116.3 571.9%  
Earnings per share (Unadj.) Rs56.617.9 316.6%  
Cash flow per share (Unadj.) Rs72.523.1 313.3%  
Dividends per share (Unadj.) Rs15.003.50 428.6%  
Dividend yield (eoy) %1.30.8 172.0%  
Book value per share (Unadj.) Rs441.785.4 517.1%  
Shares outstanding (eoy) m16.601,023.74 1.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.74.0 43.6%   
Avg P/E ratio x20.225.7 78.7%  
P/CF ratio (eoy) x15.819.9 79.5%  
Price / Book Value ratio x2.65.4 48.2%  
Dividend payout %26.519.6 135.4%   
Avg Mkt Cap Rs m19,011470,664 4.0%   
No. of employees `0001.511.8 13.1%   
Total wages/salary Rs m1,69618,545 9.1%   
Avg. sales/employee Rs Th7,150.010,072.7 71.0%   
Avg. wages/employee Rs Th1,098.71,569.1 70.0%   
Avg. net profit/employee Rs Th608.21,547.7 39.3%   
INCOME DATA
Net Sales Rs m11,040119,049 9.3%  
Other income Rs m2401,132 21.2%   
Total revenues Rs m11,279120,181 9.4%   
Gross profit Rs m1,37628,475 4.8%  
Depreciation Rs m2645,388 4.9%   
Interest Rs m0911 0.0%   
Profit before tax Rs m1,35223,308 5.8%   
Minority Interest Rs m0628 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1700-   
Tax Rs m5835,644 10.3%   
Profit after tax Rs m93918,292 5.1%  
Gross profit margin %12.523.9 52.1%  
Effective tax rate %43.124.2 178.0%   
Net profit margin %8.515.4 55.4%  
BALANCE SHEET DATA
Current assets Rs m7,52382,005 9.2%   
Current liabilities Rs m2,25360,720 3.7%   
Net working cap to sales %47.717.9 267.0%  
Current ratio x3.31.4 247.3%  
Inventory Days Days5273 71.3%  
Debtors Days Days4198 41.3%  
Net fixed assets Rs m1,24083,703 1.5%   
Share capital Rs m1661,024 16.2%   
"Free" reserves Rs m7,16786,421 8.3%   
Net worth Rs m7,33387,445 8.4%   
Long term debt Rs m025,551 0.0%   
Total assets Rs m9,912180,653 5.5%  
Interest coverage xNM26.6-  
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.10.7 169.0%   
Return on assets %9.510.6 89.1%  
Return on equity %12.820.9 61.2%  
Return on capital %20.822.0 94.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,01542,683 2.4%   
Fx outflow Rs m3,04311,242 27.1%   
Net fx Rs m-2,02831,441 -6.5%   
CASH FLOW
From Operations Rs m5379,193 5.8%  
From Investments Rs m-476-9,737 4.9%  
From Financial Activity Rs m-220515 -42.7%  
Net Cashflow Rs m-160-29 550.0%  

Share Holding

Indian Promoters % 0.0 74.8 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 8.3 219.3%  
FIIs % 1.0 5.9 16.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 11.0 264.5%  
Shareholders   28,591 44,069 64.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK With:   STERLING BIOTECH  PFIZER  ALKEM LABORATORIES  SHASUN PHARMA  SANOFI INDIA  

Compare MERCK With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex at New Highs, Jet Airways Suspends Operations - Your Inside Scoop of the Markets(Podcast)

Jet Airways, once India's largest private airline halted its operations indefinitely yesterday. The carrier flew its last scheduled flight from Amritsar to Mumbai yesterday.

Related Views on News

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

MERCK SHARE PRICE


Apr 18, 2019 (Close)

TRACK MERCK

COMPARE MERCK WITH

MARKET STATS